Metabolic engineering has enabled studying microorganisms by the modification of their genetic material and analysis of their metabolism for the isolation of microbial strains capable of producing high yields of high value chemicals and biofuels. In this research, novel tools were developed to improve genetic engineering of microbial cells. In this matter, λ-PCR (lambda-PCR) was developed enabling the construction of plasmid DNA. This technique allows DNA assembly and manipulation (insertion, substitution and/or deletion) at any location of a vector. λ-PCR addresses the need for an easy, highly-efficient, rapid and inexpensive tool for genetic engineering and overcoming limitations encountered with traditional techniques. Then, novel synthetic small RNA (sRNA) regulators were designed in a cell-free-system (in vitro) in order to modulate protein expression in biosynthetic pathways. The ability of the sRNAs to regulate mRNA expression with statistical significance was demonstrated. Up to 70% decrease in protein expression level was achieved by targeting specific secondary structures of the mRNA with antisense binding regions of the sRNA. Most importantly, a sRNA was identified capable of protein overexpression by up to 65%. An understanding of its mechanism showed that its mRNA target region(s) likely lead to occlusion of RNase E binding. This mechanism was translated for expression of a diaphorase enzyme, which has relevance to synthetic biology and metabolic engineering in in vitro systems. Results were successful, showing a greater than 75% increase in diaphorase expression in a cell-free protein synthesis reaction. Next, Raman spectroscopy was employed as a near real-time method for microbial phenotyping. Here, Raman spectroscopy was used in combination with chemometric analysis methods through RametrixTM Toolboxes to study the effects of environmental conditions (i.e. illumination, glucose, nitrate deprivation, acetate, sodium chloride and magnesium sulfate) on the phenotypic response of the cyanobacterium Synechocystis sp. PCC6803. The RametrixTM LITE Toolbox for MATLAB® enabled processing of Raman spectra and application of principal component analysis (PCA) and discriminant analysis of principal components (DAPC). Two studies were performed. PCA and DAPC produces distinct clustering of Raman spectra, representing multiple Synechocystis phenotypes, based on the (i) presence of glucose in the growth medium, (ii) illumination, (iii) nitrate limitation, and (iv) throughout a circadian rhythm growth cycle, in the first study. The second study focused on the phenotypic response based on (i) growth in presence of acetate, (ii) presence of high concentrations of sodium chloride and (iii) magnesium sulfate starvation. RametrixTM PRO was applied for the validation of the DAPC models through leave-one-out method that allowed calculation of prediction accuracy, sensitivity and selectivity for an unkown Raman spectrum. Statistical tests (ANOVA and pairwise comparison) were performed on Raman spectra to identify statistically relevant changes in Synechocystis phenotypes. Next, comparison between Raman data and standardized analytical methods (GF-FID, UPLC, spectrometric assays) was established. Overall, good correlation were obtained (R > 0.7). Finally, genomic DNA libraries were enriched to isolate a deoxynivalenol detoxifying enzyme. To do this, library fragments from microorganisms was generated through oligonucleotide primed polymerase chain reaction (DOP-PCR) and transformed in a DON-sensitive yeast strain. Rounds of subculture were performed in the presence of DON and ferulic acid in order to isolate a strain capable of enzymatic degradation of DON. / Doctor of Philosophy / Metabolic engineering is the use of genetic engineering to modify microorganisms in order to produce high yields of valuable commodity chemicals. The goal of this research is to develop new methods to improve genetic modification and selection of microbial cells. The specific objectives were to: (i) develop new tools for DNA assembly and manipulation, (ii) utilize small synthetic RNA to control protein expression level, (iii) use Raman spectroscopy to study phenotypic responses to environmental changes and (iv) enrich for microorganisms that detoxify dangerous toxins. First, a new technique for DNA assembly, named λ-PCR (lambda-PCR), was developed. This method allows the easy manipulation of plasmid DNA with high-efficiency and low-cost compared to traditional techniques. Second, novel synthetic small RNA (sRNA) regulators were designed in a cell-free-system in order to modulate (downregulate or overexpress) fluorescent protein expression. Next, Raman spectroscopy was used to assess phenotypic response of cyanobacterial cells to different environmental modifications (light settings, salts, sugar, etc…). Finally, genomic library was used to discover and characterize enzymes capable of degrading a mycotoxin.

The open nature of Cell-Free Protein Synthesis (CFPS) systems has enabled flexible design, easy manipulation, and novel applications of protein engineering in therapeutic production, biocatalysis, and biosensors. This dissertation reports on three advances in the application of CFPS systems for 1) improving biocatalysis performance in industrial applications by site-specific covalent enzyme immobilization, 2) expressing and optimizing a difficult to express a mammalian protein in bacterial-based CFPS systems and its application for cost-effective, on-demand biosensors compatible with human body fluids, and 3) streamlining the procedure of an E. coli extract with built-in compatibility with human body fluid biosensors. Site-specific covalent immobilization stabilizes enzymes and facilitates recovery and reuse of enzymes which improves the net profit margin of industrial enzymes. Yet, the suitability of a given site on the enzyme for immobilization remains a trial-and-error procedure. This dissertation reports the reliability of several design heuristics and a coarse-grain molecular simulation in predicting the optimum sites for covalent immobilization of a target enzyme, TEM-1 ?-lactamase. This work demonstrates that the design heuristics can successfully identify a subset of favorable locations for experimental validation. This approach highlights the advantages of combining coarse-grain simulation and high-throughput experimentation using CFPS to efficiently identify optimal enzyme immobilization sites. Additionally, this dissertation reports high-yield soluble expression of a difficult-to-express protein (murine RNase Inhibitor or m-RI) in E. coli-lysate-based CFPS. Several factors including reaction temperature, reaction time, redox potential, and presence of folding chaperones in CFPS reactions were altered to find suitable conditions for m-RI expression. m-RI with the highest activity and stability was used to develop a lyophilized CFPS biosensor in human body fluids which reduced the cost of biosensor test by ~90%. Moreover, an E. coli extract with RNase inhibition activity was developed and tested which further streamlines the production of CFPS biosensors compatible with human body fluids.

No presente estudo investigou-se amostras de plasma com DNA livre circulante (DNA LC) por meio da técnica Varredura Z. Esta é uma técnica eficiente na determinação de parâmetros de diferentes materiais, tais como cristais líquidos, ferrofluidos e compostos biológicos. Esta experiência é realizada através da focalização de um feixe laser de perfil gaussiano numa amostra. Na medida em que a amostra se aproxima do foco da lente, a intensidade do feixe aumenta e alcança seu valor máximo no ponto focal, então diminui para pontos distantes do foco. Na região próxima ao ponto focal se amplificam os fenômenos não-lineares. Recentemente foi demonstrado que níveis elevados de DNA LC no plasma ocorrem com frequência em pacientes com vários tipos de câncer, podendo ser utilizados para discriminar pacientes com malignidade de pessoas saudáveis. As amostras de DNA LC, submetidas ao experimento Varredura Z, forneceram respostas ópticas devido ao fenômeno de lente térmica. Os resultados revelaram que a amplitude de lente térmica das amostras extraídas do plasma de pacientes com malignidade difere daquela de doadores sãos. A técnica Varredura Z se mostrou mais vantajosa em relação a outras biológicas porque revelou uma maior diferença entre os grupos estudados e tem o caráter de detectar mudanças estruturais no DNA LC. / In the present study plasma samples with cell-free DNA were investigated by means of the Z-Scan technique. This is a powerfull technique in determining parameters of different materials, such as liquid crystals, ferrofluids and biological compounds. This experiment is performed by focusing a Gaussian profile laser beam on a sample. As the sample approaches the focus of the lens, the intensity of the beam increases and reaches its maximum value at the focal point, then decreases to points distant from the focus. In the region near the focal point non-linear phenomena are amplified. It has recently been demonstrated that high levels of plasma cell-free DNA occur frequently in patients with various cancers and can be used to discriminate patients with malignancy from healthy donors. The cell-free DNA samples, submitted to the Z-Scan experiment, provided optical responses due to the thermal lens phenomenon. The results revealed that the thermal lens amplitude of samples extracted from the plasma of patients with malignancy differs from that of healthy donors. The Z-Scan technique was more advantageous than other biological ones because it revealed a greater difference between the studied groups and has the character of detecting structural changes in cell-free DNA.

Au cours de ces dernières années, l’utilisation des acides nucléiques circulants comme outils diagnostiques et/ou pronostiques en cancérologie a largement été documentée. Récemment, le développement du diagnostic prénatal non-invasif a également révélé l’intérêt grandissant de ces biomarqueurs en gynécologie-obstétrique. Les acides nucléiques circulants ou extracellulaires ont la particularité d’être facilement détectables dans les fluides biologiques de l’organisme et sont de deux types: (1) l’ADN libre, courts ou longs fragments d’ADN provenant des processus apoptotiques et/ou nécrotiques cellulaires (2) les microARNs, petites séquences d’ARN non codantes, qui régulent l’expression des gènes en interférant avec leurs ARNm cibles. Sachant qu’il a été démontré que le taux d’ADN libre circulant est anormalement élevé dans certaines conditions pathologiques et que les microARNs sont impliqués dans la régulation de nombreux processus biologiques tels que la folliculogénèse et la stéroïdogénèse, ces deux types d’acides nucléiques pourraient alors constituer des biomarqueurs d’intérêt dans le domaine de l’Assistance Médicale à la Procréation. Dans ce travail de thèse, nous avons à la fois mesuré le taux d’ADN libre et analysé les profils d’expression de plusieurs microARNs d’intérêt par PCR quantitative, dans le liquide folliculaire (LF) de patientes prises en charge en fécondation in vitro (FIV). Nous avons observé des taux d’ADN libre significativement élevés ainsi que des profils d’expression de microARNs spécifiques dans le LF de patientes présentant des anomalies de la réserve ovarienne (telles que le syndrome des ovaires micropolykystiques ou une faible réserve ovarienne). Nous avons ensuite évalué le potentiel des acides nucléiques circulants en tant biomarqueurs prédictifs des résultats en FIV. Nous avons démontré que le taux d’ADN libre intra-folliculaire et l’expression de certains microARNs étaient significativement associés à la qualité des embryons obtenus in vitro ainsi qu’à la survenue d’une grossesse clinique. Les acides nucléiques circulants offrent donc de nouvelles perspectives à la fois d’un point de vue diagnostique et pronostique dans la prise en charge de l’infertilité humaine. / During the last years, the use of circulating nucleic acids as diagnostic and/or prognostic tools in cancerology was widely documented. The recent development of non-invasive prenatal testing also reveals the growing interest of these biomarkers in obstetrics and gynecology. The circulating or extracellular nucleic acids have for particularity to be easily detectable in the biological fluids of the body and there are two types: (1) Cell-free DNA (cfDNA), short or long DNA fragments resulting from cellular apoptosis and/or necrosis (2) microRNAs (miRNAs), small non-coding RNA sequences, which regulate gene expression by interfering with their mRNA targets. Since it was demonstrated that cfDNA level is abnormally increased in some pathological conditions and miRNAs are involved in the regulation of several biological processes such as folliculogenesis and steroidogenesis, these two types of nucleic acids could constitute new biomarkers of interest in Assisted Reproductive Technology. In this thesis work, we quantified the cfDNA level and analysed the expression profiles of some miRNAs by quantitative PCR, in follicular fluid (FF) samples from women undergoing in vitro fertilization (IVF) procedure. We observed significant high cfDNA levels as well as specific miRNA expression profiles in FF from women with ovarian disorders (such as polycystic ovary syndrome or low ovarian reserve). Next, we investigated the potential of circulating nucleic acids as predictive biomarkers of IVF outcomes. We demonstrated that the intra-follicular cfDNA level and some miRNA expressions were significantly associated with in vitro embryo quality and the clinical pregnancy outcome. Therefore, the circulating nucleic acids offer new diagnostic and prognostic perspectives in human infertility management.

Cell-free protein synthesis (CFPS) is a powerful protein expression platform where protein synthesis machinery is borrowed from living organisms. Target proteins are synthesized in a reaction tube together with cell extract, amino acids, energy source, and DNA. This reaction is versatile, and dynamic optimizations of the reaction conditions can be performed. The "œopen" nature of CFPS makes it a compelling candidate for many technologies and applications. This dissertation reports new and innovative applications of CFPS including 1) enzyme encapsulation in a virus-like particle, 2) detection of endocrine disrupting chemicals in the presence of blood and urine, and 3) expression of a multi-disulfide bond therapeutic protein. Two major limitations of enzymes are their instability and recycling difficulty. To overcome these limitations, we report the first enzyme encapsulation in the CFPS by immobilizing in a virus-like particle using an RNA aptamer. This technique allows simple and fast enzyme production and encapsulation We demonstrate, for the first time, the Rapid Adaptable Portable In vitro Detection biosensor platform (RAPID) for detecting endocrine disrupting chemicals (EDCs) in human blood and urine samples. Current living cell-based assays can take a week to detect EDCs, but RAPID requires only 2 hours. It utilizes the versatile nature of CFPS for biosensor protein complex production and EDC detection. Biotherapeutic protein expression in E. coli suffers from inclusion body formation, insolubility, and mis-folding. Since CFPS is not restricted by a cell wall, dynamic optimization can take place during the protein synthesis process. We report the first expression of full-length tissue plasminogen activator (tPA) using CFPS. These research works demonstrate the powerful and versatile nature of the CFPS.

Cell-free protein synthesis is an emerging technology that has many applications. The open nature of this system makes it a compelling technology that can be manipulated to answer many needs that are unavailable in other systems. This dissertation reports on engineering this technology for: 1) sense codon emancipation for incorporation of multiple unnatural amino acids; 2) expressing a hard-to-express anticancer biotherapeutic and introducing a just-add-water system; 3) a biosensing ligand that interacts with nuclear hormone receptors. Emancipating sense codons toward a minimized genetic code is of significant interest to science and engineering. A promising approach to sense codon emancipation is the targeted in vitro removal of native tRNA. Here we introduce a new in-vitro or "cell-free" approach to emancipate sense codons via efficient and affordable degradation of endogenous tRNA using RNase-coated superparamagnetic beads. The presented method removes greater than 99% of tRNA in cell lysates, while preserving cell-free protein synthesis activity. The resulting tRNA-depleted lysate is compatible with in vitro-transcribed synthetic tRNA for the production of peptides and proteins. Biotherapeutics have many promising applications, such as anti-cancer treatments, immune suppression, and vaccines. However, due to their biological nature, some biotherapeutics can be challenging to rapidly express and screen for activity through traditional recombinant methods. In this work, we demonstrate the use of cell-free systems for the expression and direct screening of the difficult-to-express cytotoxic protein onconase. Using cell-free systems, onconase can be rapidly expressed in soluble, active form. Furthermore, the open nature of the reaction environment allows for direct and immediate downstream characterization without the need of purification. Also, we report the ability of a "just-add-water" lyophilized cell-fee system to produce onconase. Here we introduce a Rapid Adaptable Portable In-vitro Detection biosensor platform (RAPID) for detecting ligands that interact with nuclear hormone receptors (NHRs). The biosensor is based on an engineered, allosterically-activated fusion protein, which contains the ligand binding domain from a target NHR. The presented RAPID biosensor platform is significantly faster and less labor intensive than commonly available technologies, making it a promising tool for detecting environmental EDC contamination and screening potential NHR-targeted pharmaceuticals.

Ces travaux de thèse concernent le développement d'une biopuce à membranes permettant de réincorporer de manière fonctionnelle une protéine transmembranaire de la famille des récepteurs couplés aux protéines G (RCPG), CXCR4, dans une bicouche lipidique attachée et espacée sur un substrat d'or par pilotis peptidiques (pep-tBLM), sous un format miniaturisé et parallélisé. Le peptide pilotis utilisé, P19-4H, possède une cystéine en position N-terminale pour son greffage covalent sur la surface d'or et quatre résidus Histidine en position C-terminale pour l'attachement par chélation, en présence de Nickel, de protéoliposomes réintégrant CXCR4. La synthèse de cette protéine s'effectue par expression acellulaire sous forme de protéoliposomes, dans une composition lipidique adaptée et en présence d'un lipide chélatant, le DOGS-NTA, à 2% de la quantité molaire totale des lipides. Le peptide AH, un peptide fusogène, est utilisé dans une dernière étape pour fusionner les protéoliposomes attachés. La caractérisation approfondie des protéoliposomes et l'optimisation des conditions expérimentales ont permis d'aboutir à l'attachement robuste des protéoliposomes avec une densité lipidique suffisante pour leur fusion par le peptide AH et la formation d'une pep-tBLM réintégrant CXCR4. Des études de recouvrement de fluorescence après photoblanchiment (FRAP) ont montré que la pep-tBLM réinsérant CXCR4 était fluide, homogène et continue, avec un coefficient de diffusion de 2.10-7 cm2/s. Des études d'interaction entre CXCR4 et un ligand antagoniste, le T22, ont révélé que la protéine s'insère dans la pep-tBLM de manière fonctionnelle et orientée. Le processus de formation de la pep-tBLM a été miniaturisé par microstructuration du support consistant à recouvrir la surface d'or de polystyrène puis à former des micropuits exposant la surface d'or en leur fond. Le peptide P19-4H a été déposé de manière contrôlée dans les micropuits à l'aide d'un robot de dépôt pour former des plots de pep-tBLM intégrant CXCR4. La fonctionnalité de CXCR4 réinsérée dans ces plots de membranes a été attestée par des études d'interaction avec son ligand T22. L'ensemble des étapes de formation, d'optimisation et de miniaturisation des pep-tBLM a été suivi, visualisé et caractérisé en temps réel et sans marquage par la technique d'imagerie par résonance plasmonique de surface (SPRi). La technologie « TransMembraChip » développée au cours de cette thèse représente une méthode de choix pour la réincorporation et l'étude fonctionnelle de protéines transmembranaires dans une composition lipidique adaptée. Les protéines transmembranaires, en particulier les RCPG, représentent des cibles thérapeutiques intéressantes. Ainsi, dans le cadre de la recherche de candidats médicaments pour le traitement de pathologies impliquant des protéines transmembranaires, cette nouvelle génération de biopuce à membranes constitue un outil prometteur adapté au criblage de ligands agonistes ou antagonistes de ces protéines / This thesis presents the development of a membrane biochip allowing to functionally reincorporate a transmembrane protein of the G-protein coupled receptor (GPCR) family, CXCR4, in a peptide-tethered bilayer lipid membrane (pep-tBLM), in a miniaturized and parallelized format. The peptide tether used, P19-4H, possesses a cysteine in its N-terminal extremity for covalent grafting onto the gold surface and four Histidine residues in its C-terminal extremity for attachment of proteoliposomes integrating CXCR4 by metal-chelate interaction in the presence of nickel. The synthesis of CXCR4 was carried out by cell-free expression in the form of proteoliposomes, in a suitable lipid composition and in the presence of a chelating lipid, DOGS-NTA, at 2% molar ratio. The AH peptide, a fusogenic peptide, was employed in a last step to fuse the attached proteoliposomes. The thorough characterization of proteoliposomes and the optimization of experimental conditions led to the robust attachment of proteoliposomes with sufficient lipid density to perform their fusion by the AH peptide and the formation of a pep-tBLM integrating CXCR4. Fluorescence recovery after photobleaching (FRAP) studies have shown that the pep-tBLM reinserting CXCR4 was fluid, homogeneous and continuous, with a diffusion coefficient of 2 x 10-7 cm2/s. Ligand binding studies between CXCR4 and T22, an antagonist, revealed that the protein was functional and well-oriented in the peptBLM. The formation process of the pep-tBLM was miniaturized by support microstructuration, consisting in covering the gold surface with polystyrene and then, forming microwells exposing the gold surface at their bottom. The P19-4H peptide was spotted in a controlled manner into the microwells to form microspots of pep-tBLM incorporating CXCR4. The functionality of CXCR4 reinserted into these membrane microspots was confirmed by T22 ligand binding studies. All the steps of formation, optimization and miniaturization of the pep-tBLM were monitored, visualized and characterized by surface plasmon resonance imaging (SPRi), a real time and label-free technique for the detection of interactions. The "TransMembraChip" technology developed in this work represents a method of choice for the reincorporation and functional study of transmembrane proteins in a suitable lipid composition. Transmembrane proteins, particularly GPCRs, form interesting therapeutic targets. Thus, in the context of pharmaceutical research of drug candidates for the treatment of pathologies involving transmembrane proteins, this new generation of membrane biochip is a promising tool for screening agonist or antagonist ligands of these proteins

<p>Advances in genetics, proteomics and chromatography techniques have enabled the successfully generation of a cell-free bacterial translation system composed of highly pure and active components. This system provided an ideal platform for better elucidating the mechanism of each individual step of the prokaryotic protein biosynthesis and the function of the translation factors involved in the process. </p><p>In doing so, we have discovered that the N-terminal domain or complete deletions of the ribosomal protein L11 reduced the termination efficiency of RF1 on cognate stop codons by four to six folds. The L11 deletions also conferred a two folds decrease in the missense error suggesting the increased nonsense termination accuracy of RF2 by two folds, which would clarified previous in vivo observations. </p><p>The versatility of the cell-free system has provided the additional possibility to study the effects of class II release factor RF3 mutations in mediating fast dissociation of class I release factors RF1 and RF2 from the post-termination ribosome complexes. The results show a series of mutations within RF3 conferring considerable reduction of the class I release factors recycling rate. These observations together with sequence alignment studies suggest the possible location on RF3 of the class I release factors interaction site. </p><p>In addition, the utilization of the cell-free system has made it possible to develop a new biotechnological approach for continuous production of polypeptides, based on gel filtration chromatography. The pilot trials have so far resulted in a six fold production increase of the MFTI test peptide compared to the conventional batch method.</p>

Advances in genetics, proteomics and chromatography techniques have enabled the successfully generation of a cell-free bacterial translation system composed of highly pure and active components. This system provided an ideal platform for better elucidating the mechanism of each individual step of the prokaryotic protein biosynthesis and the function of the translation factors involved in the process. In doing so, we have discovered that the N-terminal domain or complete deletions of the ribosomal protein L11 reduced the termination efficiency of RF1 on cognate stop codons by four to six folds. The L11 deletions also conferred a two folds decrease in the missense error suggesting the increased nonsense termination accuracy of RF2 by two folds, which would clarified previous in vivo observations. The versatility of the cell-free system has provided the additional possibility to study the effects of class II release factor RF3 mutations in mediating fast dissociation of class I release factors RF1 and RF2 from the post-termination ribosome complexes. The results show a series of mutations within RF3 conferring considerable reduction of the class I release factors recycling rate. These observations together with sequence alignment studies suggest the possible location on RF3 of the class I release factors interaction site. In addition, the utilization of the cell-free system has made it possible to develop a new biotechnological approach for continuous production of polypeptides, based on gel filtration chromatography. The pilot trials have so far resulted in a six fold production increase of the MFTI test peptide compared to the conventional batch method.

Head and neck squamous cell carcinoma is the fifth most common cancer worldwide. They are associated with high morbidity and mortality. Despite considerable advances in surgical and oncological treatment over the past two decades, overall treatment outcome has only slightly improved. In my thesis I focused on serum gene expression analysis of head and neck cancer patients, which followed the tissue gene expression analysis in same patients. Further we investigated gene expression analysis in tumour stroma, which is now considered as significant factor in cancer initiation and progression. We revealed several candidate genes, which are involved in signalling pathways connected with cell differentiation and proliferation and are involved in apoptotic pathway (BCl-2, BCl-XL a MAX). As well we detected down-regulation of the main tumour suppressor p 53 protein. In peritumoural tissue we detected overexpression of cytokines typical for embryonal development and ectoderm differentiation - IGF-2 and BMP-4, which significantly influence the phenotype of normal keratinocytes. Further we identified several candidate genes relating with overexpression of Gal-1 in stromal myofibroblasts rich tissue (SPIN1, FUSIP1, TRIM23, SLC25A40, PTPLAD1, MP3K2). HNSCC is a heterogeneous disease despite the presence of...